The target specificity of Anti-EGFR-Nanobody toward A549 cells and possible EPR effect of Nb@IC-NPs could play a critical role in the enrichment of O2 level and IR-1048-MZ contrast agent at the tumor site after the administration of Nb@IC-NPs. This evidence concerns the gene EGFR and neoplasm.